New tool for R&D from Symyx Tech

14 October 2007

California, USA-based Symyx Technologies has announced enhancements to its MDL Isentris informatics system, known as Symyx Isentris, giving research organizations improved ability to speed R&D experimentation, reduce costs and improve productivity. Symyx Isentris 3.0 bridges internal and external information in a single search, alerting researchers to relevant data and integrating leading scientific tools on the desktop, says the firm.

"By delivering appropriate information into workflows, Symyx Isentris 3.0 ensures that researchers make informed decisions," said Timothy Campbell, president of Symyx Software. "As researchers browse data, Isentris performs simultaneous searches in the background, flagging important toxicity data, biological activity, in-house and commercial compound availability - instantly pushing relevant information to researchers. This critical information would otherwise require multiple specific searches to find or possibly be missed," he added.

With Isentris 3.0, researchers can quickly create forms to retrieve the precise chemical and biological data they want, without relying on IT assistance. They can save sophisticated searches and use the same forms to generate comprehensive reports for sharing with colleagues.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight